Seaweeds have been used as a food for centuries in Asia and are increasingly exploited as a source for dietary supplements, animal feed, chemicals, and biofuels. In recent years, there has been an increase in the prevalence of diseases and pests in these aquaculture crops, with a subsequent reduction in their quantity and commercial value. In this article, we review diseases that have been reported in the scientific literature for species of red and brown seaweeds. We have focused on the major seaweed crops grown in Asia, where much of this production is centered. We also provide information on disease management and biosecurity and some observations on future directions.
Diseases and pests are major limiting factors to aquaculture production, 1 including seaweeds, 2 prompting global action to improve biosecurity and knowledge of important yield-limiting pathogens affecting sustainable production, both now and in the future. 3,4 Seaweeds comprise almost 30% of global aquaculture production by volume. 5 Production of the carrageenophyte red algal genera Kappaphycus and Eucheuma (collectively known as eucheumatoids) has increased rapidly in the past decade, accounting for 33.99% of global aquatic plant cultivation in 2018. 5 Eucheumatoids are commercially cultivated for production of carrageenans, polysaccharides widely used in the pharmaceutical, cosmetic and food industries.Much of this cultivation occurs in South-East Asia, particularly
Onion Allium cepa and ginger Zingiber officinale have health-promoting properties that qualify them as functional foods. The effect of repeated acute stressors was examined in juvenile Brown-marbled Grouper Epinephelus fuscoguttatus that were fed four diets supplemented with onion at 1.8%, ginger at 1.8%, vitamin C at 0.86%, and β-glucan at 0.8% of the diet. The non-supplemented diet served as the control. After 12 weeks of feeding, fish were exposed to stressors and were experimentally infected with a fish pathogen, the bacterium Vibrio harveyi JML1. After repeated exposure to hypoxia, cortisol levels rose significantly in the non-supplemented fish compared to those fed onion, ginger, β-glucan, or vitamin C. Within groups, postexposure cortisol levels in the onion-, ginger-, and vitamin C-fed fish did not change relative to pre-stress levels, whereas significant increases in poststress values were observed in the control and β-glucan groups. The net cortisol increase was also significantly greater in the non-supplemented group compared to the supplemented groups. The net cortisol increase did not vary among the supplemented groups except that the β-glucan-fed group exhibited a higher net increase than the onion-fed group. Similarly, repeated acute exposure to osmotic stress significantly increased the plasma cortisol level in the non-supplemented group compared to groups that received supplements; no differences were found in the supplemented groups except the β-glucan group. Within groups, significant increases in poststress values relative to pre-stress levels were found only in the control and β-glucan groups. Repeated acute exposure to hypoxia significantly increased cumulative mortality in the control group compared to the supplemented groups (except the β-glucan group), whereas repeated exposure to acute osmotic stress significantly increased cumulative mortality only in the control group 10 d after infection with V. harveyi JML1. Based on our collective results, most of the supplemented groups performed better than the control, but the best supplements were onion and ginger in terms of enhancing stress tolerance and increasing survival of Brown-marbled Grouper upon infection with V. harveyi JML1.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.